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Abstract 
Central nervous system infratentorial superficial siderosis (iSS) is increasingly 
detected by blood-sensitive MRI sequences. Despite this, there are no standardized 
diagnostic criteria, and the clinical-radiological spectrum, causes and optimum 
investigation strategy are not established. We reviewed clinical and radiological 
details of patients with iSS assessed at a specialist neurological center from 2004-
2016 using pre-defined standardized radiological criteria. All imaging findings were 
rated blinded to clinical details. We identified 65 patients with iSS, which we 
classified into two groups: type 1 (classical) and type 2 (secondary) iSS. Type 1 
(classical)  iSS included 48 patients without any potentially causal radiologically-
confirmed spontaneous or traumatic intracranial hemorrhage, of whom 39 (83%) had 
hearing loss, ataxia or myelopathy; type 2 (secondary) iSS included 17 patients with a 
potentially causal radiologically-confirmed spontaneous or traumatic intracranial 
hemorrhage, of whom none had hearing loss, ataxia or myelopathy. Of the patients 
with type 1 (classical) iSS, 40 (83%) had a potentially causal cranial or spinal dural 
abnormality; 5 (11%) had an alternative cause; and 3 (6%) had no cause identified. 
Intra-arterial digital subtraction angiography did not identify any underlying causal 
lesions for type 1 iSS. Type 1 (classical) iSS, defined using simple radiological 
criteria, is associated with a characteristic neurological syndrome. Rational 
investigation, including spinal MRI, nearly always reveals a potential cause, most 
often a dural abnormality. Catheter angiography appears to be unhelpful, suggesting 
that classical iSS is not associated with macrovascular arterial pathology. Recognition 
of type 1 (classical) iSS should allow timely diagnosis and early consideration of 
treatment. 
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Introduction 
 
Superficial siderosis of the central nervous system is considered to be a rare condition 
resulting from hemosiderin deposition in the subpial layers of the brain, cranial nerves 
and spinal cord.
1
 It was first described in 1908 
2
 and is hypothesized to result from an 
insidious, low volume but protracted or repetitive ‘leak’ of red blood cells into the 
subarachnoid space.
3
 In response to the resultant neurotoxic heme, Bergmann glia and 
microglia release hemoxygenase-1 and ferritin. Hemoxygenase-1 breaks down heme 
into free iron and biliverdin, while ferritin binds free iron to produce hemosiderin, a 
stable breakdown and product likely cause of radiologically detected superficial 
siderosis. Continuous subarachnoid leakage is hypothesized to eventually overwhelm 
ferritin synthesis, leading to the neuronal accumulation of neurotoxic iron and light 
chain ferritin (Fig 1), often with a very long latency (sometimes decades) between the 
presumed origin of the leak and the development of the clinical and radiological 
syndrome. The posterior fossa is most affected by siderotic deposition due to the 
abundance and close proximity of microglia and Bergmann glia in the cerebellum 
4
 
and vestibulocochlear nerve. 
5
 The cerebellar convexities and superior cerebellar 
vermis are particularly affected, often with associated atrophy, probably because of 
the pattern of CSF flow; the cerebellar convexities and flocculus are irrigated earliest 
6
 and are continuously exposed to hemorrhagic cerebrospinal fluid (CSF). 
7
 The 
olfactory and vestibulocochlear cranial nerves are also especially vulnerable: the 
olfactory nerve is a central nervous system (CNS) structure, while the eighth cranial 
nerve, in contrast to other “true” cranial nerves, has a glia limitans which is nearly 10 
mm from the medulla 
8, 9
. 
 
Until the advent of MRI, superficial siderosis of the CNS could only be inferred in 
life from clinical findings and CSF studies, with diagnostic confirmation only 
possible post mortem 
10
. With the increasing use of MRI, including blood-sensitive 
sequences, “superficial siderosis” is now a common radiological diagnosis. Two 
anatomical patterns of superficial siderosis are increasingly recognized: (1) cortical 
superficial siderosis (cSS) restricted to the supratentorial cerebral convexities, which 
(in older individuals) is often associated with cerebral amyloid angiopathy 
11, 12
 and 
transient focal neurological episodes 
13
; and (2) infratentorial superficial siderosis 
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(iSS), (with or without supratentorial involvement), which typically presents with 
slowly progressive hearing loss, ataxia and myelopathy 
1, 9
. A wide range of suggested 
causes of iSS 
9
 include subarachnoid hemorrhage from intracranial aneurysms, 
arteriovenous malformations, tumors, cerebral amyloid angiopathy, and spinal 
epidural CSF collections 
14-19
. Investigations used include MRI of the brain and spine; 
intra-arterial digital subtraction angiography of the brain or spine; CT myelography; 
20
 
and surgical exploration 
17
. While diagnostic criteria and investigation pathways for 
cSS have recently been suggested, 
21
 we are not aware of such criteria or pathways for 
iSS. There thus remains uncertainty regarding how to define, classify or investigate 
iSS.   
 
We therefore reviewed all cases of superficial siderosis assessed at our specialist 
neurological centre, aiming to: (1) describe the clinical and radiological spectrum and 
causes of iSS, using pre-defined standardized radiological criteria for iSS; and (2) 
develop a rational investigation algorithm. 
 
Patients and Methods  
We prospectively included all patients with suspected iSS referred for assessment to 
the National Hospital for Neurology and Neurosurgery, Queen Square, London (a 
tertiary neurology centre), from 20/09/2013, as well as those identified by a 
retrospective keyword search of radiological reports for the term “superficial 
siderosis” between 30/06/2004 and 30/01/2014. Two consultant neuroradiologists (FC 
and PC), and a consultant vascular neurologist (DJW) reviewed all available imaging, 
blinded to all patient details. Infratentorial superficial siderosis was defined according 
to pre-specified standardized radiological criteria based upon many years of author 
experience of reviewing imaging of patients with the typical syndrome of superficial 
siderosis of the CNS and internal author consensus: bilateral (symmetrical) well-
defined curvilinear homogeneous low signal on T2 or blood-sensitive sequences (T2* 
gradient echo or susceptibility-weighted imaging) over the superficial surface of at 
least two of the following regions: (1) brainstem (including midbrain, pons, medulla); 
(2) cerebellum (including the cerebellar folia, vermis, and cerebellar peduncles); and 
(3) spinal cord or cranio-cervical junction. The additional presence of supratentorial 
siderosis was not an exclusion criterion. In each patient the presumed epicentre and 
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distribution (both infratentorially and supratentorially) of siderosis was noted, and the 
severity of siderotic deposition was visually graded as mild (a slender rim on but 
visible on T2), moderate or severe (an obvious thick rim seen on T2). Associated 
intracerebral hemorrhage was classified as lobar or deep (including the basal ganglia, 
brainstem or cerebellum) depending on the presumed epicentre of the hemorrhage.  
 
All authors reviewed the clinical features (from all available medical records and with 
additional personal clinical evaluation by DJW, DW, MM or SF). We recorded the 
presence of the typical clinical features of “classical” iSS for each patient (we pre-
specified these as hearing loss, ataxia, or myelopathy, but also noted other 
neurological abnormalities e.g. anosmia, sphincter dysfunction, etc.). We documented 
radiological features and all other investigations (e.g. CSF analysis). We determined 
the presumed cause of iSS by consensus among all authors, based upon all available 
clinical and radiological information. 
 
The project involved only routinely collected clinical data, and was approved as a 
clinical service evaluation by the Clinical Governance department of the National 
Hospital for Neurology and Neurosurgery, University College Hospitals NHS 
Foundation Trust, and was judged not to require formal ethical committee approval. 
 
Results 
Identification of patients 
We identified 65 patients with iSS: 31 from a prospective consecutive registry of 
referrals to our service; and 34 from a retrospective radiological search (Fig 2) (Table 
1). The radiology keyword search initially yielded 111 unique patients with definite 
superficial siderosis, of whom 77 were excluded (54 with only supratentorial siderosis 
(causes shown in Table 1), and 23 with restricted infratentorial siderosis not fulfilling 
our pre-defined radiological criteria), providing a final total of 34 patients with iSS. 
None of the patients identified from this search with either isolated supratentorial 
siderosis (n=54) or restricted infratentorial siderosis (n=23) had any of the pre-defined 
“classical” clinical features of superficial siderosis of the CNS (hearing loss, ataxia, or 
myelopathy) (Table 1).  
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Clinical and radiological features of infratentorial superficial siderosis 
The median age of the 65 patients with iSS defined according to our standardized 
criteria was 56 (range, 44-65); 47 (72%) were male. We identified two distinct 
groups, classified by their presumed mechanism, which we term: Type 1 (classical) 
iSS and Type 2 (secondary) iSS. Type 1 (classical) iSS occurs where there is no 
obvious spontaneous or traumatic intracranial hemorrhage that could account for the 
observed pattern of siderosis. Type 2 (secondary) iSS occurs where there is an 
obvious single spontaneous or traumatic intracranial hemorrhage that, based on its 
spatial distribution and timing, was thought to be the likely cause of the observed 
pattern of siderosis.  
 
Type 1 (classical) infratentorial superficial siderosis  
In 48 patients had Type 1 (classical) iSS. 40 (83%) of these patients had at least one 
of the three typical clinical features of “classical” superficial siderosis of the CNS 
(hearing loss 31/40 (78%), ataxia 31/40 (78%), and myelopathy 20/40 (50%)). The 
other neurological features of Type 1 (classical) iSS included: bladder/bowel 
problems in 12/40 (30%); swallowing problems in 3/40 (8%). In the 17 patients in 
whom we had sufficient historical data to calculate the latency between the presumed 
casual event and onset of first symptoms, the median was 19 years (IQR 15 -27 years; 
range 4-50 years). All but one of patients with Type 1 (classical) iSS had symmetrical 
hemosiderin staining centered on the posterior fossa, with involvement of cerebellar 
folia, with a predilection for the superior vermis (Fig 3); a few also had less extensive 
supratentorial superficial siderosis and/or superficial siderosis of the cervical or 
thoracic spine (online supplementary Table 1).  
 
Type 2 (secondary) infratentorial superficial siderosis  
In 17 patients we identified a single episode of acute, spontaneous or traumatic 
(surgical) intracranial hemorrhage (spontaneous intracerebral hemorrhage (n=8), 
aneurysmal subrachnoid hemorrhage (n=6), intraventricular hemorrhage (n=1), 
surgical trauma associated with removal of a pineal tumor (n=1), and bilateral 
subdural hemorrhages (n=1), online supplementary Table 1). In all cases the 
intracranial hemorrhage was temporally and/or spatially associated with the 
radiological pattern of superficial siderosis, and judged by consensus to be a sufficient 
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cause of the pattern of siderosis observed. In all of these patients the siderosis 
surrounding the site of intracranial bleeding was far more extensive than the 
infratentorial superficial siderosis (which, in most cases, consisted of a slender rim of 
hemosiderin, often centered on the 4
th
 ventricle outlet (Fig 4, online supplementary 
Table 1)). None of the patients with Type 2 (secondary) iSS had a slowly progressive 
clinical syndrome, and none had any of the clinical features of “classical” superficial 
siderosis of the CNS. The mean time from the intracranial hemorrhage event to 
diagnosis on MRI for type 2 iSS was 25 months (range 11 days to 13 years). 
 
Investigation findings in type 1 (classical) infratentorial superficial siderosis  
Cranial MRI 
48/48 (100%) of the type 1 (classical) iSS patients underwent brain MR imaging. Of 
these, 45 patients (94%) had paramagnetic sequences using either T2* or SWI. 
Although the “blooming artifact” with either T2* or SWI makes hemosiderin 
deposition far more visible (Fig 3), in our cohort there were no cases where siderosis 
was only visible on T2*/SWI and not T2-weighted MRI. Relevant presumed causal 
abnormalities were found on cranial MRI in 13/48 (27%) patients. A sub-occipital 
meningocele was identified on cranial MRI in 12 patients (Fig 5, I and J); one patient 
had a large posterior fossa arachnoid cyst.  
 
Spinal MRI 
40/48 (83%) classical iSS patients underwent spinal imaging, 27 of whom had high 
resolution MRI of the spine using either SPACE or CISS sequences. Potential causal 
abnormalities were noted in 25/48 (52%) patients. An extra-arachnoid collection 
associated with a dural defect was identified in 21 patients (Fig 5 A-F: nine ventral 
spinal defects; seven posterior spinal defects; four nerve root pseudomeningoceles; 
and one anterior intracranial dural defect). Four patients had dural ectasia without an 
obvious frank dural defect (Fig 5 G and H). 
 
Intra-arterial digital subtraction angiography (IADSA) 
11/48 (23%) type 1 (classical) iSS patients underwent intra-arterial digital 
substraction angiography (IADSA): six cerebral only; two spinal only; and three both 
cerebral and spinal. IADSA did not identify any potential cause for siderosis in any of 
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the patients. 
 
CT myelography 
Five of 48 patients underwent CT myelography, which identified potential causal 
extra-arachnoid dural abnormalities in all patients: 2 patients had ventral thoracic 
extra-arachnoid collections; 2 had post-surgical posterior pseudomeningoceles; and 1 
had a nerve root avulsion and pseudomeningocele. In the 2 ventral CSF collections, 
the precise site of the dural defect was not identified on conventional CT 
myelography; in one patient the precise site of dural defect was subsequently 
identified by direct injection of contrast into the CSF collection. (Fig 6) 
 
CSF analysis 
CSF was available in 17/48 (35%) type 1 (classical) iSS patients (online supplement 
Table 1); in all cases tested, red blood cells were present but ferritin, oxyhemoglobin 
and bilirubin were only measured in a few selected cases. Where tested, ferritin was 
always raised; bilirubin was raised in 60% of patients tested, and oxyhemoglobin in 
66% of patients tested. Due to the retrospective nature of this study, detailed data on 
CSF cell counts, opening pressure, etc. were not available due to limited clinical 
documentation.  
 
Presumed causes of type 1 (classical) infratentorial superficial siderosis  
A dural abnormality was the commonest finding, found in 40/48 (83%) of patients 
with type 1 (classical) iSS patients: eight were associated with previous spinal trauma; 
21 with previous neurosurgery; three with both neurosurgery and spinal trauma; one 
with neurofibromatosis; one with Marfan’s syndrome; two with ankylosing 
spondylitis; and four of the dural abnormalities had no obvious underlying cause.  
 
Of the eight patients with no evidence of any definite dural abnormality, five had 
another potential cause of iSS identified; two pineal tumors (where the siderosis 
preceded any surgery); one spinal tumor (not operated upon); one partially 
thrombosed giant aneurysm with an enhancing wall, treated conservatively; and one 
slowly growing thalamostriate tumor, treated conservatively. Only three patients with 
classical iSS had no possible causative lesion on imaging, but none of these had 
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adequate imaging of the spine.  
 
Presumed causes of type 2 (secondary) infratentorial superficial siderosis  
Type 2 (secondary) iSS is attributable to a clear single spontaneous or traumatic 
intracranial bleeding event (e.g. sub arachnoid hemorrhage, intracerebral hemorrhage, 
or surgery) where a significant volume of blood rapidly accumulates and “spills over” 
to be deposited in the subpial layers of supratentorial and infratentorial structures. By 
contrast with type 1 (classical) iSS, none of the patients with type 2 (secondary) iSS 
had any of the typical clinical features of classical superficial siderosis, or a 
progressive neurological deterioration. Furthermore, in type 2 (secondary) iSS the 
siderosis was mainly supratentorial, while the infratentorial component was generally 
a slender hemosiderin rim, often centered around the 4
th
 ventrical outlet. It seems very 
unlikely that a high-pressure arterial leak (e.g. from an aneurysm or arteriovenous 
malformation) of the type underlying type 2 (secondary) iSS could cause a continuous 
or highly repetitive low volume hemorrhage, which may explain the lack of 
association of secondary iSS with the classical slowly progressive clinical syndrome 
that is typical of type 1 (classical) iSS.  
 
Results in the context of previous findings 
To the best of our knowledge, the largest previous single series of patients with 
superficial siderosis included 30 participants.
14
 We are not aware of previous studies 
using a similar classification scheme for iSS 
9
. The high incidence of dural 
abnormalities we found in type 1 (classical) iSS is consistent with a previous case 
series 
14
 as well as a number of case reports 
16, 17, 22, 23
. Furthermore case reports show 
bleeding and venous abnormalities occur at the site of a dural tears 
15, 16, 22, 24-26
 
27, 28
. 
However, our findings differ from some previous reports on the causes of type 1 
(classical) iSS; although arteriovenous malformations have been reported to cause 9% 
of cases of superficial siderosis of the CNS
9
 we found none, and only one very 
atypical aneurysm, visible on plain MRI, with a contrast enhancing wall. There were 
no other cranial or spinal macrovascular lesions in our type 1 (classical) iSS cohort. 
While CAA has been suggested to account for 3% of cases of superficial siderosis of 
the CNS 
9
, we did not find any cases of CAA as a cause of type 1 (classical) iSS; 
moreover patients with CAA-related secondary iSS did not have any of the “classical” 
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iSS clinical features of hearing loss, ataxia or myelopathy. We identified some rarer 
causes of type 1 (classical) iSS. Neurofibromatosis was the presumed cause of type 1 
(classical) iSS in two patients, in keeping with previous single case reports.
29, 30
 
Neurofibromatosis, ankylosing spondylosis, Marfan’s syndrome and arachnoid cysts 
might all cause iSS by injury or distortion of the dura, leading to a weak point and a 
source of slow blood leakage through communication with the subarachnoid space. 
 
Our clinical observations, including a long and slowly progressive history with a 
characteristic clinical syndrome as well as a symmetrical and stereotyped pattern of 
iSS, are consistent with the hypothesis that type 1 (classical) iSS results from 
continuous or repetitive low-volume subarachnoid hemorrhage which is disseminated 
and hemolysed in the CSF. This suggests the bleeding source is slow, under low 
pressure, probably of microvascular or venous origin, and most likely to arise in the 
spine or posterior fossa at the site of a dural defect. The lack of any macrovascular 
abnormalities on craniospinal IADSA in type 1 (classical) iSS argues against a 
macroscopic arterial bleeding point. In our series, neurosurgery, often many years 
prior to the development of clinical or radiological features of infratentorial 
superficial siderosis, was a common association with type 1 (classical) iSS.  
 
 
Strengths and limitations 
Our study has some important strengths; using overlapping methods of case 
ascertainment, we identified both consecutively referred and retrospectively identified 
patients over a long period, providing, to the best of our knowledge, the largest single 
reported case series of patients with iSS. We used pre-defined standardized 
radiological diagnostic criteria, with review (blinded to clinical details) by two 
certified consultant vascular neuroradiologists and a consultant vascular neurologist 
with a specialist interest in superficial siderosis. 
 
Our study also has some limitations; we included referrals to a hospital specialist 
centre, which might cause selection bias. Our pre-specified radiological criteria are 
based upon consensus derived from previous publications and our extensive 
combined multidisciplinary team clinical experience, rather than a formal consensus 
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group, and have not been validated in other populations. Clinical information from 
standard healthcare records may have been incomplete. We do not have long-term 
follow-up data to exclude the possibility that those with type 2 iSS might 
subsequently develop symptoms of type 1 (classical) iSS. However, we think that this 
is unlikely: firstly, none of the patients with type 2 (secondary) iSS presented with or 
subsequently developed any symptoms suggesting type 1 (classical) iSS (hearing loss, 
ataxia or myelopathy; and second, the radiological features, underlying causes and 
clinical presentations suggest that type 1 (classical) and type 2 (secondary) iSS are 
distinct entities. Finally, over the time period of the study, secular trends in 
investigation (e.g. the wider use of high resolution spinal imaging and CT 
myelography) may have affected our detection of potential underlying causes, though 
the high rate of finding an underlying diagnosis suggests that this was not a major 
problem.  
 
 
Clinical implications  
Our study, including a large case series of 65 patients with infratentorial superficial 
siderosis, confirms a broad clinical and radiological spectrum with numerous different 
causes. We build on previous observations on superficial siderosis by developing a 
classification, which we hope will be of value to clinicians faced with the clinical and 
radiological syndrome of iSS. Using simple pre-defined standardized radiological 
criteria, we describe two distinct groups of iSS based on presumed etiology, which 
have different clinical and radiological profiles: type 1 (classical) iSS occurs in the 
absence of any obvious single intracranial bleeding event and is associated with a 
slowly progressive neurological deterioration, usually including combinations of 
deafness, ataxia and myelopathy. Type 2 (secondary) iSS, is clearly attributable to a 
single spontaneous or post-traumatic intracranial bleeding event and is not associated 
with slowly progressive neurological deterioration. With a combination of targeted 
cranial and spinal imaging methods we found a likely underlying cause of iSS in 94% 
of patients with type 1 (classical) iSS. IADSA (catheter angiography) of the brain 
and/or spine did not contribute to detecting a cause for iSS in any patients in our 
cohort. 
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Based on our observations, we also propose a rational diagnostic algorithm to follow 
when superficial siderosis is detected on imaging (Fig 7). Using this approach, we 
identified a cause for type 1 (classical) superficial siderosis in 45 of 48 patients 
(94%). The very small proportion without an underlying diagnosis in our series (three 
patients, 6%) is much lower than the 35% of unexplained or “idiopathic” cases 
suggested in the literature.
9
 Furthermore, these three patients did not have adequate 
spinal MRI available, so might have had a cause identified if our recommended 
algorithm was followed. The high diagnostic yield (and frequent finding of dural 
abnormalities) in our study is likely due to our systematic use of cranial and spinal 
imaging.  
 
While there is no treatment proven to alter the natural history of classical 
infratentorial superficial siderosis, there is preliminary evidence for the safety and 
tolerability of deferiprone, an iron-chelating drug, which crosses the blood brain 
barrier 
31-33
. Although iron chelation has unproven efficacy in iSS, it has been 
associated with possible clinical or radiological improvement 
31-36
 and decreased 
ferritin in the CSF.
37
 However, agranulocytosis is a potentially serious side effect of 
deferiprone.
35
 Thus, whether iron chelation might lead to clear clinical benefit in iSS 
remains unproven; randomized controlled trials are needed to test this hypothesis, but 
will be challenging due to the rarity and slow progression of iSS. An observational 
trial of deferiprone in superficial siderosis (ClinicalTrials.gov Identifier: 
NCT01284127), with a planned follow up period of 2 years, has completed 
recruitment but is not yet published. Iron chelation therapy has also been investigated 
in other neurological disorders including neurodegeneration with brain iron 
accumulation; although it can decrease cerebral iron content assessed by MRI, there is 
currently no compelling evidence that iron removal has beneficial effects in any 
neurological disorder.
38
  
 
Observational reports suggest that defining and treating causal structural anomalies 
(e.g. surgical repair or blood patches to seal dural defects 
17
) might be of benefit, but 
large scale controlled studies are lacking. Nevertheless, we suggest that it is important 
to recognize the typical clinical and radiological pattern of type 1 (classical) iSS to 
ensure rational investigation, timely diagnosis and early consideration of treatment 
(ideally in the context of randomised controlled trials); our proposed diagnostic 
Page 12 of 34
John Wiley & Sons
Annals of Neurology
This article is protected by copyright. All rights reserved.
 13
criteria and investigation pathway should help to facilitate this goal.   
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Figure Titles and Legends 
 
Figure 1: Pathophysiology of type 1 classical infratentorial siderosis 
 
Figure 2: Flow chart of patients in study. 
 
Figure 3: Type 1 (classical) infratentorial superficial siderosis shown on T2-weighted 
axial magnetic resonance image (A) and corresponding T2*-weighted GRE magnetic 
resonance image (B) showing the typical pattern of hemosiderin centered on the 
cerebellar vermis (white arrows). Note the “blooming effect on the T2*-weighted 
GRE image (B) compared to the T2-weighted image (A).  
Legend: GRE –gradient recalled echo  
 
 
Figure 4: Type 2 (secondary) infratentorial superficial siderosis, caused by a deep 
basal ganglia intracerebral hemorrhage, shown on axial T2*-weighted GRE magnetic 
resonance images. Note that the infratentorial superficial siderosis consists of only a 
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slender rim of hemosiderin, centered around the fourth ventricle outlet and extending 
towards the cranio-cervical junction (white arrows) 
Legend: GRE –gradient recalled echo  
 
 
Figure 5: Imaging examples of dural defects associated with infratentorial superficial 
siderosis. (A) and (B) show a nerve root pseudomeningocele (white arrow) on sagittal 
T2-weighted spinal MRI (A) and axial T2-weighted spinal MRI (B); (C) and (D) 
show a large posterior spinal CSF collection (white arrow) on sagittal T2-weighted 
spinal MRI (C) and axial T2-weighted spinal MRI (D); (E) and (F) show an anterior 
spinal CSF collection (white arrow) – in this patient probably related to previous 
trauma - on sagittal T2-weighted spinal MRI (E) and axial T2-weighted spinal MRI 
(F); (G) and (H) show dural ectasia in a patient with Marfan’s syndrome (white 
arrow) on sagittal T2-weighted spinal MRI (G) and axial T2-weighted spinal MRI 
(H); (I) and (J) show a sub-occipital pseudomeningocele on axial T2-weighted MRI 
(I) and sagittal T2-weighted MRI with associated siderosis over the superior folia of 
the cerebellar vermis. 
 
Figure 6: CT myelography in the investigation of infratentorial superficial siderosis: 
(A) CT myelography showing ventral extra-arachnoid spinal collection in the upper 
thoracic region; (B) Transforaminal injection into the ventral extra-arachnoid 
collection; (C) MRI image showing ventral extra-arachnoid spinal collection (note 
that differentiation of extra arachnoid CSF collection from epidural fat can be 
difficult); (D) Direct injection of dense contrast into the ventral upper thoracic 
collection fills the cavity in a gravity-dependent fashion (the arrow shows the point at 
which the contrast first enters the sub-arachnoid space at T2/3, revealing the precise 
level of the dural defect). 
 
Figure 7: Proposed investigation and treatment algorithm in patients with superficial 
siderosis detected on neuroimaging 
 
Legend: CAA–cerebral amyloid angiopathy, RCVS–reversible cerebral 
vasoconstriction syndrome, IADSA–intra-arterial digital subtraction angiography, 
CISS - Constructive Interference in Steady State, SPACE - Single-Slab 3-
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Dimensional T2-weighted Turbo-Spin-Echo Sequence With High Sampling 
Efficiency 
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Pathophysiology of type 1 classical infratentorial siderosis  
Fig 1  
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Flow chart of patients in study.  
Fig 2  
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Type 1 (classical) infratentorial superficial siderosis shown on T2-weighted axial magnetic resonance image 
(A) and corresponding T2*-weighted GRE magnetic resonance image (B) showing the typical pattern of 
hemosiderin centered on the cerebellar vermis (white arrows). Note the “blooming effect on the T2*-
weighted GRE image (B) compared to the T2-weighted image (A).  
Legend: GRE –gradient recalled echo  
 
Fig 3  
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Type 2 (secondary) infratentorial superficial siderosis, caused by a deep basal ganglia intracerebral 
hemorrhage, shown on axial T2*-weighted GRE magnetic resonance images. Note that the infratentorial 
superficial siderosis consists of only a slender rim of hemosiderin, centered around the fourth ventricle outlet 
and extending towards the cranio-cervical junction (white arrows)  
Legend: GRE –gradient recalled echo  
 
Fig 4  
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Imaging examples of dural defects associated with infratentorial superficial siderosis. (A) and (B) show a 
nerve root pseudomeningocele (white arrow) on sagittal T2-weighted spinal MRI (A) and axial T2-weighted 
spinal MRI (B); (C) and (D) show a large posterior spinal CSF collection (white arrow) on sagittal T2-
weighted spinal MRI (C) and axial T2-weighted spinal MRI (D); (E) and (F) show an anterior spinal CSF 
collection (white arrow) – in this patient probably related to previous trauma - on sagittal T2-weighted spinal 
MRI (E) and axial T2-weighted spinal MRI (F); (G) and (H) show dural ectasia in a patient with Marfan’s 
syndrome (white arrow) on sagittal T2-weighted spinal MRI (G) and axial T2-weighted spinal MRI (H); (I) 
and (J) show a sub-occipital pseudomeningocele on axial T2-weighted MRI (I) and sagittal T2-weighted MRI 
with associated siderosis over the superior folia of the cerebellar vermis.  
Fig 5  
254x190mm (300 x 300 DPI)  
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CT myelography in the investigation of infratentorial superficial siderosis: (A) CT myelography showing 
ventral extra-arachnoid spinal collection in the upper thoracic region; (B) Transforaminal injection into the 
ventral extra-arachnoid collection; (C) MRI image showing ventral extra-arachnoid spinal collection (note 
that differentiation of extra arachnoid CSF collection from epidural fat can be difficult); (D) Direct injection of 
dense contrast into the ventral upper thoracic collection fills the cavity in a gravity-dependent fashion (the 
arrow shows the point at which the contrast first enters the sub-arachnoid space at T2/3, revealing the 
precise level of the dural defect).  
Fig 6  
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Proposed investigation and treatment algorithm in patients with superficial siderosis detected on 
neuroimaging  
 
Legend: CAA–cerebral amyloid angiopathy, RCVS–reversible cerebral vasoconstriction syndrome, IADSA–
intra-arterial digital subtraction angiography, CISS - Constructive Interference in Steady State, SPACE - 
Single-Slab 3-Dimensional T2-weighted Turbo-Spin-Echo Sequence With High Sampling Efficiency  
 
Fig 7  
170x127mm (300 x 300 DPI)  
 
 
Page 26 of 34
John Wiley & Sons
Annals of Neurology
This article is protected by copyright. All rights reserved.
  
 
 
Pathophysiology of type 1 classical infratentorial siderosis (Greyscale version for print)  
Fig 1  
170x127mm (300 x 300 DPI)  
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Table 1. Causes of superficial siderosis in all patients identified from our prospective 
consecutive registry and retrospective radiological search.   
 
* Dural abnormalities included the following: pseudomeningocoele; extra-arachnoid CSF collection; dural ectasia, etc. Some 
of these dural abnormalities were related to previous surgery or trauma, often many years earlier (see Online Supplementary 
Table 1 for details). 
** These patients had infratentorial superficial siderosis which was not present  bilaterally (symmetrically) in at least two of 
the following regions: (1) brainstem (including midbrain, pons, medulla); (2) cerebellum (including the cerebellar folia, 
vermis, and cerebellar peduncles); and (3) spinal cord or cranio-cervical junction. 
Presumed cause of 
superficial siderosis 
Isolated 
supratentorial 
superficial siderosis, 
n=54 
Restricted 
infratentorial 
superficial siderosis 
not fulfilling 
diagnostic criteria,  
n=23** 
Type 1 (classical) 
infratentorial 
superficial siderosis, 
n=48  
Type 2 (secondary) 
infratentorial 
superficial siderosis, 
n=17 
Intracerebral 
Hemorrhage (+/-
convexity SAH) 
28 (52%) 6 (26%) 0 9 (53%) 
Traumatic contusions 
 
16 (30%) 3 (13%) 0 0 
Aneurysmal SAH 
 
5 (9%) 3 (13%) 1 (2%) atypical 
aneurysm with slow 
rather than acute SAH 
6 (35%) 
Ruptured AVM 
 
2 (4%) 1 (4%)  0 0 
Cerebral Venous 
Sinus Thrombosis 
1 (2%) 1 (4%) 0 0 
Non aneurysmal 
(perimesencephalic) 
SAH 
0 1 (4%) 0 0 
Surgical trauma 
directly causing 
hemorrhage and 
related siderosis  
 
2(4%) 4 (17%) 0 1 (6%) 
Subdural hemorrhage 
 
0 1 (4%) 0 1 (6%) 
Dural abnormality* 
 
0 0 40 (83%) 0 
Tumor 
 
0 0 4 (9%) 0 
Spinocerebellar ataxia 
with associated brain 
iron accumulation 
 
0 1 (4%) 0 0 
Hemorrhagic 
transformation of an 
infarct 
 
0 1 (4%) 0 0 
Cause identified 
 
54 (100%) 22 (96%) 45 (94%) 17 (100%) 
No cause identified 0 1 (4%) 3 (6%); (none had 
adequate spinal 
imaging) 
0 
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Supplementary Table 1: Characteristics of the patients with Type 1 (classical) and Type 2 (secondary) infratentorial superficial 
siderosis. 
 Siderosis pattern 
(qualitative burden, presumed 
epicentre, extension supra or 
infratentorially) 
Symptoms of classical 
infratentorial  
superficial siderosis 
(hearing loss, ataxia, 
myelopathy) 
History of cranial-
spinal trauma or 
surgery 
Latency between 
known antecedent 
event (trauma, 
surgery) and 
symptoms or 
diagnosis  
Likely cause of siderosis CSF findings 
1 Severe, centred on posterior fossa Hearing loss, myelopathy, 
ataxia, sphincter symptoms 
Cerebellar pilocytic 
astrocytoma excised  
Unknown Suboccipital pseudomeningocele 
following neurosurgery 
Xanthochromia, 
ferritin 134, red 
cells 10750 
2 Moderate/severe, hemosiderin centred on 
the posterior fossa  
Ataxia and myelopathy Occipital craniotomy Unknown Suboccipital pseudomeningocele 
following neurosurgery 
Not available 
3 Moderate, centred on the posterior fossa 
with involvement of the spine 
Hearing loss, ataxia, 
myelopathy, urinary 
symptoms, fatigue, headaches 
No Not applicable Posterior fossa arachnoid cyst Not available 
4 Severe, centred on posterior fossa Ataxia and hearing loss and 
detruser instability 
Occipital craniectomy 
for Chiari Type 1 
malformation 
Unknown Suboccipital pseudomeningocele 
following neurosurgery 
Xanthochromia,  
spectophotometric 
peak consistent 
with bilirubin 
5 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends to the 
cervical spine inferiorly and the Sylvian 
fissures supratentorially  
Hearing loss, ataxia, urinary 
symptoms, diplopia 
RTA Fracture C2/3. 
Spinal surgery 
cauterisation of bleeding 
point 
20 years Ventral spinal dural defect, 
secondary to spinal trauma 
Not available 
6 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends to the 
cervical spine inferiorly and the Sylvian 
fissures supratentorially 
Hearing loss Spinal surgery for 
diastomatomyelia at age 
2 years 
Unknown Spinal dural defect following 
surgery 
Not available 
7 Mild, hemosiderin centred on the 
posterior fossa  
Gait deterioration No Not applicable Mid thoracic dural ectasia 
secondary to Neurofibromatosis 
Type 1 
Not available 
8 Moderate/severe, centred on the posterior 
fossa Less prominent siderosis extends to 
the cervical spine inferiorly and the 
Sylvian fissures supratentorially 
Ataxia, myelopathy, reduced 
hearing on right 
Left sided brachial 
plexus injury 
14 years Ventral spinal dural defect 
following brachial plexus injury 
Red cells 570, 
trace 
xanthochromia 
9 
 
Mild, centred on the posterior fossa  No; Migraine and BPPV C7 neurofibroma 
excised 
Unknown C6/7 nerve root psuedomeningocele 
following neurosurgery 
Not available 
 
 
10 Moderate, centred on the posterior fossa Hearing loss and ataxia Brain tumour removed Unknown Intracranial dural defect following Not available 
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and extending up as far as the 
interhemispheric fissure 
in childhood surgery 
11 Moderate, centred on the posterior fossa. 
Siderosis extends to the cervical spine 
inferiorly 
No; Headaches only No Not applicable Spinal dural ectasia secondary to 
Marfan's syndrome 
Not available 
12 Mild, centred on the posterior fossa and 
cervical spinal cord 
No; Left shoulder weakness 
and wasting with absent 
reflexes. 
Brachial plexus injury Unknown Ventral spinal collection following 
brachial plexus injury 
Not available 
13 Mild, centred on the posterior fossa and 
cervical cord 
Lower limb myelopathy, leg 
ataxia, reduced 
proprioception to the knees. 
Teratoma excised from 
thoracic cord 
Unknown Posterior spinal dural defect 
following neurosurgery 
Red cells 650, 
bilirubin 0.007, 
oxyhemaglobin 
0.011, ferritin 131 
14 Mild, centred on the posterior fossa and 
cervical spine. Less prominent siderosis 
extends up as far as the Sylvian fissures  
Mild myelopathy Yes occipital 
craniotomy for Chiari 
Type 1 malformation 
27 years Sub occipital psuedomeningocele 
following neurosurgery 
Not available 
15 Severe, centred on the posterior fossa. 
Less prominent siderosis extends up as 
far as the cerebral hemispheres 
No; headache and vomiting 
only 
No Not applicable Ventral spinal collection without 
obvious cause 
Not available 
16 Severe, centred on the posterior fossa. 
Less prominent siderosis extends up as 
far as the cerebral hemispheres including 
the interhemispheric fissure. 
Ataxia, hearing loss and 
myelopathy 
No Not applicable Ventral spinal collection without 
obvious cause 
Red cells 5600 
17 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends up as 
far as the cerebral hemispheres including 
the interhemispheric fissure 
Hearing loss, ataxia, anosmia, 
myelopathy 
Fall with spinal injury  15 years Ventral spinal collection secondary 
to spinal trauma 
Not available 
18 Mild, centred on the cervical spine  Myelopathy, hearing loss, 
fatigue, bladder and sexual 
dysfunction 
Occipital craniotomy for 
Chiari Type 1 
malformation  
15 years Sub-occipital psuedomeningocele 
following neurosurgery 
Not available 
19 Moderate/Severe, centred on the posterior 
fossa. Less prominent siderosis extends 
up as far as the cerebral hemispheres 
including the interhemispheric fissure 
Hearing loss, ataxia, hearing 
loss. 
Cerebellar astrocytoma 
resected aged 10. 
Subsequent resection 
and shunt 
17 years Sub-occipital psuedomeningocele 
following neurosurgery 
Not available 
20 Moderate/severe, centred on the posterior 
fossa and cervical spine. Less prominent 
siderosis extends up as far as the cerebral 
hemispheres including the 
interhemispheric fissure. 
Hearing loss and vestibular 
dysfunction. 
C8-T1 nerve root 
avulsion  
39 years Nerve root avulsion and 
psuedomeningocele following 
spinal injury 
Red cells 8961  
21 Moderate/severe, centred on the posterior 
fossa. Less prominent siderosis extends 
up as far as the cerebral hemispheres 
including the interhemispheric fissure  
Hearing loss, ataxia, 
myelopathy 
Assault to spine 15 years Ventral spinal collection and dural 
defect at the cervico-thoracic 
junction following spinal injury 
Ferritin 114,  
bilirubin 0.065, 
oxyhemoglobin 
0.055 
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22 Severe, centred on the posterior fossa and 
cervical spine. Less prominent siderosis 
extending to the cerebral hemispheres 
including the interhemispheric fissure 
Hearing loss, ataxia and 
myelopathy, blowel and 
bladder dysfunction. 
Posterior fossa surgery 
Bilateral VA dissection, 
right PICA bypass 
4 years Sub-occipital psuedomeningocele 
following neurosurgery 
Red cells 920 
23 Severe, centred on the posterior fossa 
with involvement of the spinal cord. Less 
prominent siderosis extends up as far as 
the cerebral hemispheres including the 
interhemispheric fissure fissures  
Hearing loss and ataxia Occipital craniectomy - 
(Medulloblastoma 
resected) 
7 years Sub occipital psuedomeningocele 
following neurosurgery 
Yes “Red cells” 
24 Mild, centred on the posterior fossa with 
and cervical spinal cord 
Ataxia, swallowing problems, 
mild myelopathy 
Hangman’s fracture 
C1/2  
19 years Nerve root psuedomeningocele at 
C7 following high cervical trauma 
Not available 
25 Mild, centred on the posterior fossa  Myelopathy  Spinal surgery-
arachnoid cyst removed. 
Residual multiloculated 
arachnoid cyst 
Unknown Posterior dural defect, with  thoracic 
psuedomeningocele following 
neurosurgery 
Red cells 650, 
ferritin 78 
26 Moderate, centred on the posterior fossa, 
extends to the Sylvian fissures and 
cervical cord 
No No Not applicable Dural ectasiawith evidence of low 
cerebral spinal fluid pressure 
Not available 
27 Mild, centred on the posterior fossa  Ataxia and hearing loss since 
2013 
Cranio cervical surgery 
for epenymoma 
18 years Sub occipital psuedomeningocele 
following neurosurgery 
Not available 
28 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends up as 
high as the Sylvian fissures  
Ataxia, hearing loss, some 
difficulties swallowing 
No Not applicable Dural ectasia secondary to 
ankalosing spondilitis  
Not available 
29 Mild, centred on the posterior fossa  Hearing loss, ataxia and 
myelopathy 
Occipital craniectomy Unknown Sub occipital psuedomeningocele 
following neurosurgery 
Not available 
30 Mild, centred on the posterior fossa 
Extend to the cervical cord. 
Hearing loss No Not applicable Posterior spinal collection upper 
thoracic cord with dural defect – 
possible arachnoid cyst 
Not available 
31 Severe, centred on the posterior fossa. 
Less prominent siderosis extends to the 
Sylvian fissures  
Hearing loss, constipation, 
loss of proprioception to 
knees 
Spinal surgery  T11 
meningioma resection  
19 years Posterior (lateral) dural defect T11 
following neurosurgery 
Not available 
32 Moderate, centred on the posterior fossa Ataxia,hearing loss, urinary 
frequency, slurred speech, 
swallowing problems 
 
Spinal ependymoma  20 years Sub occipital psuedomeningocele 
following neurosurgery 
Not available 
33 Moderate to severe, centred on the 
posterior fossa  
Ataxia, hearing loss, 
dysarthria. 
Road traffic accident; 
right brachial plexus 
avulsion; C6-T1 
laminectomy and repair 
of pseudo-meningocoele 
41 years Nerve root psuedomeningocele C8, 
previous trauma and neurosurgery 
Not available 
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34 Moderate, centred on the posterior fossa 
and cervical spine Extends up to occipital 
lobes  
Ataxia, hearing loss and 
myelopathy 
Road traffic accident; 
Brachial plexus injury 
aged 14. Associated 
Spinal surgery 
32 years Posterior dural defect spine  and 
psuedomeningocele C5-T5 
secondary to spinal trauma 
Not available 
35 Moderate to severe, centred on the 
posterior fossa, Extends to Sylvian 
fissures supratentorially and lumbar  
spine 
Ataxia, hearing loss 
 
Post fossa surgery 
intracranial intradural 
surgery Skull base 
chordoma 
Unknown Intracranial dural defect secondary 
to neurosurgery 
 
Red cells 1600 
36 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends up to 
the interhemispheric  fissure, cervical and 
thoracic spine 
Ataxia and hearing loss 
 
Fall and spinal trauma  50 years Ventral spinal collection secondary 
to spinal trauma 
 
Not available 
37 Severe, centred on the posterior fossa and 
cervical spine. Less prominent siderosis  
extends up to the interhemispheric fissure 
Ataxia, Hearing loss, mild 
myelopathy, Urinary 
symptoms, anosmia 
No Not applicable Dural ectasia – secondary to 
Ankolysing spondilitis 
Res cells 2200, 
siderophages, 
ferritin 163, 
xanthochromia, 
oxyhemoglobin 
and bilirubin 
present. 
38 Moderate, centred on the posterior fossa 
and cervical spine 
Ataxia and mild myelopathy Yes cervical disc 
surgery 
Unknown Ventral spinal collection secondary 
to neurosurgery 
Xanthochromia  
39 Mild posterior fossa siderosis at the 
cranio-cervical junction and cerebellar 
vermis 
No; dysarthria Medulloblastoma 
resection 
Not applicable Sub occipital psuedomeningocele 
secondary to neurosurgery 
Not available 
40 Moderate, centred on the posterior fossa 
and cervical spine 
Ataxia, hearing loss and 
myelopathy, incontinence 
“Whiplash injury” Unknown Ideopathic (no adequate spinal 
imaging) 
Red cells 1900, 
ferritin 52 
41 Severe, centred on the posterior fossa. 
Less prominent siderosis extends up as 
far as the Sylvian fissures  
Hearing loss, ataxia, 
myelopathy 
No Not applicable Ideopathic (no spinal imaging) Ferritin 58, 
bilirubin absent 
42 Mild/moderate, centred on the posterior 
fossa. Less prominent siderosis extends to 
the cervical spine inferiorly and the 
Sylvian fissures supratentorially 
No. Severe Alzheimer’s 
disease 
No Not applicable Partially thrombosed giant basilar 
tip aneurysm with wall 
enhancement 
Not available 
43 Mild, centred on the posterior fossa  No No Not applicable Spinal tumour No 
44 Severe, centred on the posterior fossa. 
Moderate/heavy hemosiderin staining in 
cerebral hemispheres supratentorially and 
cervical cord 
Hearing loss, ataxia and 
detrusor instability 
Cystic hemorrhagic 
tumour thalamostriate 
Multiple shunts 
Unknown Tumour Not available 
45 Severe, centred on the posterior fossa Ataxia No Not applicable Ideopathic (no spinal imaging) Not available 
46 Severe, centred on the posterior fossa Ataxia and hearing loss  Post fossa surgery Unknown Posterior fossa /pineal region cyst Red cells 1268 
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extending up to the interhemispheric 
fissures. 
 brainstem mass (Pineal 
tumour) treated 
endoscopically 
with blood products in it. 
47 Moderate, centred on the posterior fossa. 
Less prominent siderosis extends up to 
interhemispheric fissures 
Ataxia, incontinence and 
cognitive decline 
Posterior fossa surgery 
for a pineal tumour 
Unknown Pineal tumour Multiple CSF due 
to ventriculitis, 
Red cells 85 to 
>2000 
48 Mild, centred on the posterior fossa Hearing loss and low pressure 
syndrome 
Cervical disc surgery Unknown Ventral spinal collection secondary 
to spinal surgery 
Not available 
49 
 
Speckled siderosis, slight asymmetry 
more prominent in right posterior fossa.  
No No 9 months Aneurysmal SAH Not available 
50 Symmetrical posterior fossa siderosis, 
Large ICH (with surrounding siderosis, 
more prominent than infratentorial 
compartment) with ventricular spread. 
No No Unknown Lobar parenchymal ICH  Not available 
51 Slender layer of siderosis centred around 
the 4th ventricle outlet. Parenchymal ICH 
has more prominent siderosis than 
infratentorial compartment 
No No 2 years Lobar parenchymal ICH  Not available 
52 Heavy siderosis load in sylvian fissures 
and cisterns of suprtentorial compartment 
in addition to symmetrical infratentorial 
siderosis in infratentorial structures. 
Frank hematoma within the chiasmatic 
cystern 
No No 1 month Aneurysmal SAH  Not available 
53 Assymetric supratentorial hemosiderin 
and slender subtle hemosiderin deposition 
in post fossa and cranial cervical junction 
No External ventricular 
shunts required for SAH 
12 years Aneurysmal SAH Not available 
54 Slender hemosiderin in posterior fossa 
associated with heavy burden of 
hemosiderin supratentorially 
No Craniotomy and external 
ventricular shunts 
13 years Previous surgery with associated 
lobar ICH 
Not available 
55 Slender subtle hemosiderin in 
infratentorial structures 
No No 12 days Aneurysmal SAH Not available 
56 Slender hemosiderin centred around 4 
ventricle outflow with large burden of 
siderosis surrounding supratentorial 
parenchymal ICH 
No No 11 months Deep ICH with IVH extension Not available 
57 Slender hemosiderin centred around 4 
ventricle outflow with large burden of 
siderosis supratentorially and around 
shunt tracts 
No External ventricular  
shunts  
6 months Aneurysmal SAH Not available 
58 Slender hemosiderin centred around 4 No Pineal tumour removed 1 month Heavy bleeding around surgical site Not available 
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 Legend: ICH: intracerebral hemorrhage; SAH: subarachnoid hemorrhage; CSF cerebral spinal fluid;  
ventricle outflow with large burden of 
siderosis supratentorially and around 
surgical site 
59 Slender hemosiderin centred around 4 
ventricle outflow with large burden of 
siderosis supratentorially around ICH 
No No 3 months Intraventricular ICH Not available 
60 Prominent posterior fossa hemosiderin 
and extensive hemosiderin surrounding 
ICH 
No No 7 months Lobar parenchymal ICH Not available 
61 Slender hemosiderin centred around 4 
ventricle outflow with large burden of 
siderosis from multiple supratentorial 
ICHs 
No No 2 years Deep and lobar parenchymal ICH Not available 
62 Very thin slender posterior fossa 
hemosderin  
No No 8 months Bilateral subdural hemorrhages Not available 
63 Slender hemosiderin centred around 4th 
ventricle outflow with large burden of 
siderosis supratentorially around ICH 
No No 8 months Lobar parenchymal ICH Not available 
64 Predominantly supratentorial siderosis 
with multiple surgical interventions and 
known SAH. Only very thin posterior 
fossa siderosis 
No Multiple  external 
ventricular shunts  
2 years 5 months Aneurysmal  SAH Not available 
65 Slender hemosiderin centred around 4 
ventricle outflow with large burden of 
siderosis supratentorially around ICH 
No No 15 days Deep parenchymal ICH Not available 
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